Methylprednisolone sodium succinate

Methylprednisolone sodium succinate.

Beneficial interactions 1. Prevent nausea and vomiting caused by tumor chemotherapy: 2. Chemotherapy regimens for mild to moderate vomiting: Chlorinated phenothiazines can be used in combination with the first dose of methylprednisolone (1 hour before chemotherapy) to enhance the effect. 3. Chemotherapy regimens for severe vomiting: Metoclopramide or butyrophenone drugs can be used in combination with the first dose of methylprednisolone (1 hour before chemotherapy) to enhance the effect. 4. This product can be used in combination with other anti-tuberculosis chemotherapy to treat fulminant or diffuse pulmonary tuberculosis and tuberculous meningitis with subarachnoid obstruction or tendency to obstruction. 5. This product is often used in combination with alkylating agents, anti-metabolites and vinca alkaloids for tumor diseases such as leukemia and lymphoma. Harmful interactions 1. The combination of this product with ulcer-causing drugs (such as salicylates and non-steroidal anti-inflammatory drugs) will increase the risk of gastrointestinal complications. 2. The combination of this product with thiazide diuretics will increase the risk of impaired glucose tolerance. 3. This product will increase the demand for insulin and oral hypoglycemic drugs in diabetic patients. 4. Patients receiving this product should not be vaccinated with cowpox or receive other immunization measures, especially those taking large doses, because there is a risk of neurological complications and/or lack of antibody response. 5. This product should be used with caution in combination with acetylsalicylic acid in patients with hypoprothrombin. 6. There are reports that taking this product and cyclosporine at the same time can cause convulsions. Because the above two drugs inhibit each other's metabolism, convulsions and other side effects caused by taking either drug are more likely to occur when taking both drugs at the same time.

Methylprednisolone sodium succinate.

Beneficial interactions - Prevention of nausea and vomiting caused by cancer chemotherapy: - Mild to moderate emetogenic chemotherapy regimens: Chlorothiazines can be used in combination with the first dose of methylprednisolone (1 hour before chemotherapy) to enhance the effect. - Severe emetogenic chemotherapy regimens: Metoclopramide or butyrophenones can be used in combination with the first dose of methylprednisolone (1 hour before chemotherapy) to enhance the effect. - Methylprednisolone can be used in combination with other antituberculosis chemotherapy to treat fulminant or disseminated pulmonary tuberculosis and tuberculous meningitis with subarachnoid obstruction or tendency to obstruction. - Methylprednisolone is often used in combination with alkylating agents, antimetabolites, and vinca alkaloids for neoplastic diseases such as leukemia and lymphoma. Harmful interactions - Glucocorticoids and ulcerogenic drugs (such as salicylates and N.S.A.I.